Imunon Inc - Company Profile

All the sales intelligence you need on Imunon Inc in one solution.

Save hours of research time with a comprehensive
Sales Intelligence Solution.
Understand how Imunon Inc fits into your total
addressable market and Ideal Customer Profile.
Gain competitive edge with triggers that tell you
when and how to engage with Imunon Inc.

Imunon Inc: Premium Databases

Contact the team or request a demo to find out how our data can drive your business forward

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Headline	Published	Journalists
Showing 3 of 4 results.
Deserunt mollit sunt Lorem laborum do id aliqua dolore	22 Jan 2019	Lorem
Celsion’s EGEN-001 not yet at dose-limiting toxicity level; first milestone tied to Phase II ovarian cancer trial – execs	30 Jul 2014	Kathleen Raven
Gem has picked CMO and CRO for Phase II sarcoma trial - CEO	20 Mar 2014	Casey McDonald
Celsion’s ThermoDox HCC treatment may struggle to show PFS benefit - experts	12 Oct 2012	Kotaro Yoshida

Delivers exclusive investigative journalist content including breaking news and analysis ahead of market-moving events.

Drug Insights:

Forward-looking, nuanced, qualitative asset analysis on development, approval & market/reimbursement potential
Material intelligence on competitors, including breaking news
Insight on companies’ business development needs and strategies

Outsourcing Insights:

Insight on companies’ CRO and business development needs, strategies and relationships

Remove risk and uncertainty

Gain a competitive edge

Secure actionable leads

Gain a 360-degree view of Imunon Inc and make more informed decisions for your business

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer